Fig. 3From: Establishment and characterization of a new intrahepatic cholangiocarcinoma cell line derived from a Chinese patientDrug sensitivity of the RBE and ICC-X1 cells. Dose–effect graphs of paclitaxel (A, E), gemcitabine (B, F), 5-FU (C, G), and oxaliplatin (D, H) in the ICC-X1 and RBE cellsBack to article page